Project leader

Professor Martin Gotthardt, MD
Phone:+312 436 109 72

Project staff

Annemarie Eek, MSc (project manager)
Phone:+312 436 672 43

 

Dr. Maarten Brom, PhD (postdoc)
Phone:+312 436 190 97

 

Dr. Mijke Buitinga, PhD (postdoc)
Phone:+312 436 673 19

 

Marti Boss, MSc (PhD student)
Phone:+312 436 673 19

Institute presentation

The Radboud University Medical Centre is a leading Dutch institute for medical research. The Department of Radiology and Nuclear Medicine provides state-of-the-art radionuclide imaging and therapy with radiolabeled tracers. Nowadays, also fluorescently labeled tracers are used in both a pre-clinical and clinical setting.

The department is equipped with 3 SPECT or SPECT/CT scanners and a state-of-the-art time of flight PET-CT scanner. Yearly more than 10,000 diagnostic SPECT procedures and 1,500 PET procedures are performed in the out-patient clinic of the department. In addition, the department has facilities to treat cancer patients with high activity doses of radiolabeled compounds such as [I-131]-iodide, [I-131]-MIBG and I-131/Lu-177/Y-90/Re-186-labeled antibodies and peptides for radionuclide therapy.
 
In the radiopharmacy laboratory of the department more than 30 different radiopharmaceuticals can be prepared under full GMP conditions. Besides the activities for the management of patients, the department has an extensive research program and is involved in the education of medical and life science students.
 
More than 35 people (nuclear medicine physicians, nuclear medicine residents, nuclear medicine technologists, radiopharmacists, a.o.) are responsible to carry out the clinical tasks at the nuclear medicine section of the department, while approximately 25 employees (nuclear medicine physicians, radiochemist, physicists, junior investigators, senior investigators, research technicians) are actively involved in the clinical and preclinical research activities with tracer molecules.
Print
Top